Docket #: S20-136
Injectable Supramolecular Hydrogels for Bioprinting, Wound Healing, and Drug Delivery
Stanford scientists have invented a new suite of adaptable hydrogel biomaterials that are optically transparent and injectable for cell encapsulation, tissue engineering, and drug delivery.
Recent efforts to develop hydrogel biomaterials have focused on better recapitulating the dynamic properties of the native extracellular matrix using adaptable hydrogels in which the binding thermodynamics and crosslink kinetics directly affect numerous bulk dynamic properties such as strength, stress relaxation, and material clearance. However, despite the broad range of bulk dynamic properties observed in biological tissues, present strategies to incorporate dynamic linkages in cell encapsulating hydrogels rely on a relatively small number of dynamic covalent chemical reactions and host-guest interactions.
Stanford scientists have developed supramolecular gelatin hydrogels with cucurbit[8]uril (CB[8])-based crosslinks that display useful properties, including being optically transparent and injectable. Human fibroblast cells encapsulated within these hydrogels remained highly viable and exhibited a well-spread morphology in culture. These CB[8]-based gelatin hydrogels are anticipated to be useful in applications ranging from bioprinting to cell and drug delivery.
Applications
- Wound healing
- Regenerative medicine
- 3D cell culture
- Bioprinting
- Drug delivery
Advantages
- Optically transparent
- Injectable
- Shear-thinning
- Demonstrated ability to encapsulate fibroblasts and keep them viable
Related Links
Patents
- Published Application: WO2021173698
- Published Application: 20230040418
Similar Technologies
-
Stretchable, tunable conducting polymer hydrogels for implantable devices and tissue engineering S18-129Stretchable, tunable conducting polymer hydrogels for implantable devices and tissue engineering
-
Drug-imprinted hydrogel for controlled-release wound healing therapy with FAK inhibitors S14-447Drug-imprinted hydrogel for controlled-release wound healing therapy with FAK inhibitors
-
Injectable and Stable Hydrogels with Dynamic Properties Modulated by Biocompatible Catalysts S16-344Injectable and Stable Hydrogels with Dynamic Properties Modulated by Biocompatible Catalysts